ASX:PME

Pro Medicus (PME) Stock Forecast, Price & News

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 285,954 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: 0.43%
Price Target: N/A

Profile Chart Competitors Dividend Insider Trades Headlines

About Pro Medicus (ASX:PME) Stock

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Receive PME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro Medicus and its competitors with MarketBeat's FREE daily newsletter.

PME Stock News Headlines

May 27, 2023 | finance.yahoo.com

Investors in Pro Medicus (ASX:PME) have seen fantastic returns of 726% over the past five years

May 25, 2023 | msn.com

CRITERION: This ASX biotech is the sole dedicated player in a new $420 billion market

June 3, 2023 | Vantage Point (Ad)

We Called (ARWR) In Advance, Which Stocks Are Next?

Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE.

April 30, 2023 | finance.yahoo.com

Pro Medicus (ASX:PME) Knows How To Allocate Capital Effectively

April 19, 2023 | msn.com

CSL shares dip despite new FDA approval

March 24, 2023 | finance.yahoo.com

Despite recent sales, Pro Medicus Limited (ASX:PME) insiders still hold the largest share with a 53% interest

March 16, 2023 | msn.com

Founders sell off $125 million worth of this ASX 200 company’s stock. What’s going on?

February 18, 2023 | msn.com

ASX shares: Invest in these 2 stocks for a legit chance at $1 million

June 3, 2023 | Legacy Research (Affiliate) (Ad)

“Amazon Loophole” could hand you $28,544 in “royalty” payouts

Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.

February 8, 2023 | finance.yahoo.com

Visage 7 Named Best in KLAS 2023

January 30, 2023 | msn.com

4 ASX 200 shares hitting new 52-week highs on Monday

January 26, 2023 | uk.finance.yahoo.com

Pro Medicus Limited's (ASX:PME) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

January 23, 2023 | msn.com

This ASX 200 healthcare share just hit a new 52-week high. Here’s why

January 9, 2023 | fool.com.au

Pro Medicus Limited shares rocket: Is this the next hot stock?

December 18, 2022 | ca.finance.yahoo.com

Pro Medicus (ASX:PME) sheds 4.1% this week, as yearly returns fall more in line with earnings growth

November 27, 2022 | finance.yahoo.com

Visage Announces Support of Amazon HealthLake Imaging

November 21, 2022 | yahoo.com

Under The Bonnet, Pro Medicus' (ASX:PME) Returns Look Impressive

November 1, 2022 | fool.com.au

Two 5-bagger health tech ASX shares ready to rocket again: expert

October 21, 2022 | fool.com.au

This ASX 200 share turned $10k into $1 million in just 10 years

October 21, 2022 | fool.com.au

This ASX 200 share has ‘all the qualities of a compounder’: experts

October 14, 2022 | finance.yahoo.com

Insiders at Pro Medicus Limited (ASX:PME) must be dismayed with the latest 3.3% dip after buying recently

September 21, 2022 | finance.yahoo.com

With EPS Growth And More, Pro Medicus (ASX:PME) Makes An Interesting Case

September 16, 2022 | markets.businessinsider.com

2 ASX stocks just received a “Perfect 10” Smart Score

September 16, 2022 | markets.businessinsider.com

Here’s 2 ASX stocks that just received a “Perfect 10” Smart Score

September 2, 2022 | afr.com

Pro Medicus Limited

August 21, 2022 | fool.com.au

Pro Medicus share price tipped to rise amid ‘strong long-term growth story’

August 18, 2022 | afr.com

Pro Medicus dodges the tech wreck as profits soar

See More Headlines

PME Company Calendar

Ex-Dividend for 3/23 Dividend: 3/01/2023
Dividend Payable: 3/23/2023
Today: 6/03/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: ASX
Industry: Health Information Services
Sub-Industry: N/A
Sector: Computer and Technology
Current Symbol: ASX:PME
CUSIP: N/A
CIK: N/A
Web: www.promed.com.au
Phone: 61 3 9429 8800
Fax: N/A
Employees: 2,060
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A$0.49
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: 3.87
Net Income: $50.95 million
Net Margins: 47.77%
Pretax Margin: N/A
Return on Equity: 48.05%
Return on Assets: 27.99%

Debt

Debt-to-Equity Ratio: 1.74
Current Ratio: 5.50
Quick Ratio: 4.39

Sales & Book Value

Annual Sales: $106.67 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 71.76
Book Value: A$1.12 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 104,430,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 0.58

Key Executives

Dr. Sam Aaron Hupert M.B.B.S.
M.D., Co-Founder, CEO, MD & Exec. Director

Mr. Anthony Barry Hall B.Sc.
B.Sc.(Hons), M.Sc., Co-Founder, Technology Director & Exec. Director

Mr. Clayton James Hatch CPA
B.Comm, CPA, CFO & Company Sec.

Dr. Malte Westerhoff
GM of Europe & Global CTO

Mr. Brad Levin
GM of North America & Global Head of Marketing

Mr. Sean Lambright
Global Head of Sales - Visage Imaging Inc

Ms. Teresa Gschwind
Global Head of Customer Service of Visage Imaging Inc.

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

PME Stock - Frequently Asked Questions

How often does Pro Medicus pay dividends? What is the dividend yield for Pro Medicus?: Pro Medicus announced a Interim dividend on Thursday, March 2nd. Stockholders of record on Thursday, March 23rd will be given a dividend of 0.13 per share on Thursday, March 23rd. This represents a dividend yield of 0.22%. The ex-dividend date of this dividend is Wednesday, March 1st. This is an increase from the stock's previous Interim dividend of A$0.07.
Read our dividend analysis for PME.
Is Pro Medicus a good dividend stock?: Pro Medicus (ASX:PME) pays an annual dividend of A$0.26 per share and currently has a dividend yield of 0.43%. The dividend payout ratio is 53.06%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for PME.
What other stocks do shareholders of Pro Medicus own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Pro Medicus investors own include ImmuPharma (IMM), Blackmores (BKL), Bank of America (BAC), Boeing (BA), Accent Group (AX1), Axos Financial (AX), ARB (ARB), Appen (APX), Arista Networks (ANET) and Altium (ALU).

What is Pro Medicus' stock symbol?: Pro Medicus trades on the ASX under the ticker symbol "PME."
How much money does Pro Medicus make?: Pro Medicus (ASX:PME) has a market capitalization of $0.00 and generates $106.67 million in revenue each year. The company earns $50.95 million in net income (profit) each year or A$0.49 on an earnings per share basis.
How many employees does Pro Medicus have?: The company employs 2,060 workers across the globe.
How can I contact Pro Medicus?: The official website for the company is www.promed.com.au. The company can be reached via phone at 61 3 9429 8800.

This page (ASX:PME) was last updated on 6/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial